Gene · 79885
Papers2,024
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,024
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| First report on analysis of chemical space, scaffold diversity, critical structural features of HDAC11 inhibitors. | Mol Divers | 2025 | 40380989 | PubTator, text mining | PubMed |
| Histone modifications and metabolic reprogramming in tumor-associated macrophages: a potential target of tumor immunotherapy. | Front Immunol | 2025 | 40375990 | PubTator, text mining | PubMed |
| Chemopreventive and therapeutic effects of Hippophae rhamnoides L. fruit peels evaluated in preclinical models of breast carcinoma. | Front Pharmacol | 2025 | 40371330 | PubTator, text mining | PubMed |
| Augmenting the Anti-Leukemic Activity of the BCL-2 Inhibitor Venetoclax Through Its Transformation Into Polypharmacologic Dual BCL-2/HDAC1 and Dual BCL-2/HDAC6 Inhibitors. | Drug Dev Res | 2025 | 40370107 | PubTator, text mining | PubMed |
| Sp4/HD11 and Sp1/HAT-p300 complexes induce apoptotic cell death in CuCl2-treated neurons by modulating histone acetylation on BCL-W and BAX promoters. | Neurochem Int | 2025 | 40185277 | PubTator, text mining | PubMed |
| HDAC11 Inhibition as a Potential Therapeutic Strategy for AML: Target Identification, Lead Discovery, Antitumor Potency, and Mechanism Investigation. | J Med Chem | 2025 | 40177883 | PubTator, text mining | PubMed |
| Discovery of De Novo Macrocycle Inhibitors of Histone Deacetylase 11. | JACS Au | 2025 | 40151233 | PubTator, text mining | PubMed |
| Targeting Histone Deacetylase 11 with a Highly Selective Inhibitor for the Treatment of MASLD. | Adv Sci (Weinh) | 2025 | 39976110 | PubTator, text mining | PubMed |
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients. | ACS Pharmacol Transl Sci | 2025 | 39974640 | PubTator, text mining | PubMed |
Construction of a Cancer Stem Cell related Histone Acetylation Regulatory Genes Prognostic Model for Hepatocellular Carcinoma via Bioinformatics Analysis: Implications for Tumor Chemotherapy and Immunity. | Curr Stem Cell Res Ther | 2025 | 38561604 | PubTator, text mining | PubMed |
| Immunometabolism: signaling pathways, homeostasis, and therapeutic targets. | MedComm (2020) | 2024 | 39492834 | PubTator, text mining | PubMed |
| Histone deacetylase expression following cisplatin-induced acute kidney injury in male and female mice. | Am J Physiol Renal Physiol | 2024 | 39116350 | PubTator, text mining | PubMed |
| Molecular Mechanisms Underlying Loss of Vascular and Epithelial Integrity in Irritable Bowel Syndrome. | Gastroenterology | 2024 | 39004156 | PubTator, text mining | PubMed |
| Utilization of an optimized AlphaFold protein model for structure-based design of a selective HDAC11 inhibitor with anti-neuroblastoma activity. | Arch Pharm (Weinheim) | 2024 | 38996352 | PubTator, text mining | PubMed |
| Biological function and small molecule inhibitors of histone deacetylase 11. | Eur J Med Chem | 2024 | 38972077 | PubTator, text mining | PubMed |
| [Progress on the involvement of HDAC11 in the regulation of mammalian oocyte maturation and early embryonic development]. | Sheng Li Xue Bao | 2024 | 38939938 | PubTator, text mining | PubMed |
| Emerging role of HDAC11 in skeletal muscle biology. | Front Cell Dev Biol | 2024 | 38859964 | PubTator, text mining | PubMed |
| shRNA-mediated gene silencing of HDAC11 empowers CAR-T cells against prostate cancer. | Front Immunol | 2024 | 38835760 | PubTator, text mining | PubMed |
| Sulfur(VI) Fluoride Exchange Chemistry in Solid-Phase Synthesis of Compound Arrays: Discovery of Histone Deacetylase Inhibitors. | JACS Au | 2024 | 38818074 | PubTator, text mining | PubMed |
| Unraveling HDAC11: Epigenetic orchestra in different diseases and structural insights for inhibitor design. | Biochem Pharmacol | 2024 | 38788962 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79885/papers?page=4